Study | n | Age (Years) | Viral Status (C/B/C+B) | Alcohol Intake@ (No/Yes) | Tumor Size (mm) | Tumor no | Child Pugh (A/B) | Treatment (Surgery/Local) | Follow up |
---|---|---|---|---|---|---|---|---|---|
Mizuta et al. | |||||||||
Treatment | 32 | 63.3 ± 7.5 | 28/3/1 | 10/22 | 17.7 ± 5.1 | 1.5 ± 0.9 | 26/6 | 1/31 | 28.9 (± 8.3) |
Control | 29 | 64.5 ± 6.7 | 26/2/1 | 3/26 | 19.4 ± 6.9 | 1.5 ± 0.7 | 22/7 | 3/26 | 27.7 (± 8.6) |
Kakizaki et al. | |||||||||
Treatment | 30 | 69.1 ± 5.9 | 30/0/0 | 6/24 | 20.4 ± 11.6 | 19/11 | 22/8 | 4/26/0 | 36 |
Control | 30 | 69.0 ± 7 | 30/0/0 | 3/27 | 25.0 ± 9.4 | 22/8 | 22/8 | 7/23/0 | 36 |
Hotta et al. | |||||||||
Treatment | 21 | 14/6 | 18/3* | 15/6 | 15/6 | 2/19 | |||
Control | 21 | 3/19 | 18/6* | 12/12 | 12/12 | 2/22 | |||
Yoshiji et al. | |||||||||
Treatment | 18* | 62.8 ± 7.4 | 15/0 | 8/10 | 17.9 ± 9.2 | 1.6 ± 0.9 | 16/2 | 0/18 | 36 |
Control | 25 | 60.5 ± 8.5 | 1/3 | 12/13 | 18.7 ± 9.5 | 1.6 ± 0.9 | 20/5 | 0/25 | 36 |
Yoshida et al. | |||||||||
Treatment# | 367 | 68.6 ± | 305/38 | 140/227 | 19.9 ± 7.6 | 1.4 ± 0.7 | 323/44 | 14/353 | 37 |
Control | 181 | 7.9 | 150/20 | 79/102 | 20.3 ± 7.6 | 1.4 ± 0.7 | 154/27 | 7/174 | 37 |